DK171826B1 - Ca2+-afhængigt monoklonalt antistof mod protein C, hybridomacellelinie til produktion af antistoffet, fremgangsmåde til isolation af protein C, fremgangsmåde til fremstilling af antistoffet og polypeptid til brug ved fremgangsmåden - Google Patents
Ca2+-afhængigt monoklonalt antistof mod protein C, hybridomacellelinie til produktion af antistoffet, fremgangsmåde til isolation af protein C, fremgangsmåde til fremstilling af antistoffet og polypeptid til brug ved fremgangsmåden Download PDFInfo
- Publication number
- DK171826B1 DK171826B1 DK209090A DK209090A DK171826B1 DK 171826 B1 DK171826 B1 DK 171826B1 DK 209090 A DK209090 A DK 209090A DK 209090 A DK209090 A DK 209090A DK 171826 B1 DK171826 B1 DK 171826B1
- Authority
- DK
- Denmark
- Prior art keywords
- protein
- antibody
- hpc
- peptide
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/04—Phospholipids, i.e. phosphoglycerides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29244788A | 1988-12-30 | 1988-12-30 | |
US29244788 | 1988-12-30 | ||
PCT/US1989/005851 WO1990007524A1 (en) | 1988-12-30 | 1989-12-28 | Monoclonal antibody against protein c |
US8905851 | 1989-12-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK209090A DK209090A (da) | 1990-08-30 |
DK209090D0 DK209090D0 (da) | 1990-08-30 |
DK171826B1 true DK171826B1 (da) | 1997-06-23 |
Family
ID=23124711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK209090A DK171826B1 (da) | 1988-12-30 | 1990-08-30 | Ca2+-afhængigt monoklonalt antistof mod protein C, hybridomacellelinie til produktion af antistoffet, fremgangsmåde til isolation af protein C, fremgangsmåde til fremstilling af antistoffet og polypeptid til brug ved fremgangsmåden |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0407544B1 (fi) |
JP (1) | JP2559537B2 (fi) |
KR (1) | KR940002033B1 (fi) |
AT (1) | ATE122057T1 (fi) |
AU (2) | AU641634B2 (fi) |
CA (1) | CA2006684C (fi) |
DE (1) | DE68922491T2 (fi) |
DK (1) | DK171826B1 (fi) |
ES (1) | ES2074562T3 (fi) |
FI (1) | FI101476B1 (fi) |
WO (1) | WO1990007524A1 (fi) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5298599A (en) * | 1988-12-30 | 1994-03-29 | Oklahoma Medical Research Foundation | Expression and purification of recombinant soluble tissue factor |
AT402262B (de) * | 1991-06-20 | 1997-03-25 | Immuno Ag | Arzneimittel enthaltend aktiviertes protein c |
AU4784693A (en) * | 1992-07-24 | 1994-02-14 | Oklahoma Medical Research Foundation | Blockade of protein c activation reduces microvascular surgical blood loss |
DK0658168T3 (da) * | 1992-08-27 | 2001-01-22 | Sanquin Bloedvoorziening | Antistoffer, som er specifikke for et hæmostatisk protein, anvendelse heraf til isolering af intakt protein, hæmostatiske p |
DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
US5532136A (en) * | 1993-06-22 | 1996-07-02 | Bionebraska, Inc. | Monoclonal antibody assay and kit for detecting metal cations in body fluids |
JPH08512323A (ja) * | 1993-07-09 | 1996-12-24 | スミスクライン・ビーチャム・コーポレイション | タンパク精製方法 |
HRP940645A2 (en) * | 1993-10-06 | 1996-12-31 | Immuno Ag | Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained |
AU710106B2 (en) * | 1994-06-10 | 1999-09-16 | Oklahoma Medical Research Foundation | Calcium binding recombinant antibody against protein c |
TW200407335A (en) | 2002-07-22 | 2004-05-16 | Chugai Pharmaceutical Co Ltd | Non-neutralizing antibody to inhibit the inactivation of activated protein C |
LT2708559T (lt) | 2008-04-11 | 2018-06-11 | Chugai Seiyaku Kabushiki Kaisha | Antigeną surišanti molekulė, galinti pakartotinai prisijungti prie dviejų ar daugiau antigeno molekulių |
EP2647706B1 (en) * | 2010-11-30 | 2023-05-17 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
MX352889B (es) | 2011-02-25 | 2017-12-13 | Chugai Pharmaceutical Co Ltd | Anticuerpo de fc especifico para fcyriib. |
US20150050269A1 (en) | 2011-09-30 | 2015-02-19 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities |
TWI673063B (zh) * | 2013-09-20 | 2019-10-01 | 日商中外製藥股份有限公司 | 抗蛋白c抗體之出血性疾病的治療 |
MY183415A (en) | 2014-12-19 | 2021-02-18 | Chugai Pharmaceutical Co Ltd | Anti-c5 antibodies and methods of use |
SG11201700841QA (en) | 2014-12-19 | 2017-03-30 | Chugai Pharmaceutical Co Ltd | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use |
US11359009B2 (en) | 2015-12-25 | 2022-06-14 | Chugai Seiyaku Kabushiki Kaisha | Anti-myostatin antibodies and methods of use |
MX2019001448A (es) | 2016-08-05 | 2019-09-13 | Chugai Pharmaceutical Co Ltd | Composicion para profilaxis o tratamiento de enfermedades relacionadas con interleucina 8 (il-8). |
JP7191833B2 (ja) | 2017-01-30 | 2022-12-19 | 中外製薬株式会社 | 抗スクレロスチン抗体およびその使用 |
-
1989
- 1989-12-27 CA CA002006684A patent/CA2006684C/en not_active Expired - Lifetime
- 1989-12-28 WO PCT/US1989/005851 patent/WO1990007524A1/en active IP Right Grant
- 1989-12-28 AU AU49683/90A patent/AU641634B2/en not_active Expired
- 1989-12-28 EP EP90902092A patent/EP0407544B1/en not_active Expired - Lifetime
- 1989-12-28 ES ES90902092T patent/ES2074562T3/es not_active Expired - Lifetime
- 1989-12-28 AT AT90902092T patent/ATE122057T1/de not_active IP Right Cessation
- 1989-12-28 JP JP2502801A patent/JP2559537B2/ja not_active Expired - Lifetime
- 1989-12-28 KR KR1019900701945A patent/KR940002033B1/ko not_active IP Right Cessation
- 1989-12-28 DE DE68922491T patent/DE68922491T2/de not_active Expired - Lifetime
-
1990
- 1990-08-29 FI FI904262A patent/FI101476B1/fi active IP Right Grant
- 1990-08-30 DK DK209090A patent/DK171826B1/da not_active IP Right Cessation
-
1993
- 1993-07-28 AU AU44228/93A patent/AU669540B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AU669540B2 (en) | 1996-06-13 |
DK209090A (da) | 1990-08-30 |
FI904262A0 (fi) | 1990-08-29 |
DE68922491T2 (de) | 1995-11-09 |
WO1990007524A1 (en) | 1990-07-12 |
FI101476B (fi) | 1998-06-30 |
AU4968390A (en) | 1990-08-01 |
AU641634B2 (en) | 1993-09-30 |
ATE122057T1 (de) | 1995-05-15 |
EP0407544A1 (en) | 1991-01-16 |
CA2006684A1 (en) | 1990-06-30 |
CA2006684C (en) | 1996-12-17 |
ES2074562T3 (es) | 1995-09-16 |
KR910700266A (ko) | 1991-03-14 |
JP2559537B2 (ja) | 1996-12-04 |
KR940002033B1 (ko) | 1994-03-14 |
EP0407544B1 (en) | 1995-05-03 |
JPH03504332A (ja) | 1991-09-26 |
FI101476B1 (fi) | 1998-06-30 |
DE68922491D1 (de) | 1995-06-08 |
AU4422893A (en) | 1994-01-27 |
DK209090D0 (da) | 1990-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5336610A (en) | Method for purification of the zymogen of protein C or the heavy chain thereof using monoclonal antibody HPC-4 | |
DK171826B1 (da) | Ca2+-afhængigt monoklonalt antistof mod protein C, hybridomacellelinie til produktion af antistoffet, fremgangsmåde til isolation af protein C, fremgangsmåde til fremstilling af antistoffet og polypeptid til brug ved fremgangsmåden | |
US7501117B2 (en) | Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV | |
US5260274A (en) | Factor VIII binding domain of von Willebrand Factor | |
US5679639A (en) | Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation | |
USRE38202E1 (en) | Antibodies specific for a haemostatic protein, their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein | |
US5279956A (en) | Activated protein C polypeptides and anti-peptide antibodies, diagnostic methods and systems for inhibiting activated protein C | |
US5190919A (en) | Antihemostatic factor vii peptides | |
EP0972781B1 (en) | Proteins polypeptides and uses thereof | |
CA1258242A (en) | Urokinase zymogen and composition containing the same | |
EP0592600B1 (en) | Proteins s polypeptides and uses thereof | |
CA2105863A1 (en) | Compositions and methods to inhibit the activation of active factor xiii | |
JPS6062981A (ja) | 線維素溶解酵素 | |
JPH04218368A (ja) | プラスミノーゲン・アクチベーター前駆体の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PUP | Patent expired |